Does hepatocellular carcinoma develop after treatment of Wegener's granulomatosis with cyclophosphamide?
Ueno
Takato
T
Sata
Michio
M
D006528:Carcinoma, Hepatocellular / Q000139:chemically induced*; D003520:Cyclophosphamide / Q000009:adverse effects* / Q000627:therapeutic use; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000139:chemically induced*; D009153:Mutagens / Q000009:adverse effects* / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D009153:Mutagens; D003520:Cyclophosphamide